Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Setien, Sonia
41  Ergebnisse:
Personensuche X
?
1

Switch to ocrelizumab in MS patients treated with natalizum..:

Santiago-Setien, Pilar ; Barquín-Rego, Cristina ; Hernández-Martínez, Paula...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Does Extended Interval Dosing Natalizumab Preserve Effectiv..:

Riancho, Javier ; Setien, Sonia ; Sánchez de la Torre, Jose Ramón...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
3

A novel SGCE variant is associated with myoclonus-dystonia ..:

Delgado-Alvarado, Manuel ; Matilla-Dueñas, Antoni ; Altadill-Bermejo, Antonio...
Neurological Sciences.  41 (2020)  12 - p. 3779-3781 , 2020
Link: https://doi.org/10.1007/..
 
?
4

Polymorphisms in the presenilin 1 and presenilin 2 genes an..:

Combarros, Onofre ; Alvarez-Arcaya, Amaya ; Oterino, Agustı́n...
Journal of the Neurological Sciences.  171 (1999)  2 - p. 88-91 , 1999
Link: https://doi.org/10.1016/..
 
?
5

Switch to ocrelizumab in MS patients treated with natalizum..:

Santiago-Setien, Pilar ; Barquín-Rego, Cristina ; Hernández-Martínez, Paula...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929864/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Switch to ocrelizumab in MS patients treated with natalizum..:

Santiago-Setien, Pilar ; Barquín-Rego, Cristina ; Hernández-Martínez, Paula...
1664-3224.  , 2023
Link: https://hdl.handle.net/1..
 
?
7

Does Extended Interval Dosing Natalizumab Preserve Effectiv..:

Riancho Zarrabeitia, Javier ; Setien, Sonia ; Sánchez de la Torre, Jose Ramón...
https://www.doi.org/10.3389/fimmu.2021.614715.  , 2021
Link: http://hdl.handle.net/10..
 
?
8

Does Extended Interval Dosing Natalizumab Preserve Effectiv..:

Riancho, Javier ; Setien, Sonia ; Sánchez de la Torre, Jose Ramón...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027344/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Switch to ocrelizumab in MS patients treated with natalizum..:

Pilar Santiago-Setien ; Cristina Barquín-Rego ; Paula Hernández-Martínez...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1086028/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
10

Does Extended Interval Dosing Natalizumab Preserve Effectiv..:

Javier Riancho ; Sonia Setien ; Jose Ramón Sánchez de la Torre...
https://www.frontiersin.org/articles/10.3389/fimmu.2021.614715/full.  , 2021
Link: https://doi.org/10.3389/..
 
?
11

Epigenetic inactivation of the 5-methylcytosine RNA methylt..:

Ortiz-Barahona, Vanessa ; Soler, Marta ; Davalos, Veronica...
Molecular Cancer.  22 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
12

Analysis of the circRNA and T-UCR populations identifies co..:

Siqueira, Edilene ; Obiols-Guardia, Aida ; Jorge-Torres, Olga C....
Molecular Therapy - Nucleic Acids.  27 (2022)  - p. 621-644 , 2022
Link: https://doi.org/10.1016/..
 
?
13

The transcribed ultraconserved region uc.160+ enhances proc..:

Soler, Marta ; Davalos, Veronica ; Sánchez‐Castillo, Anaís...
Molecular Oncology.  16 (2021)  3 - p. 648-664 , 2021
Link: https://doi.org/10.1002/..
 
?
14

Epigenetic loss of the transfer RNA-modifying enzyme TYW2 i..:

Rosselló-Tortella, Margalida ; Llinàs-Arias, Pere ; Sakaguchi, Yuriko...
Proceedings of the National Academy of Sciences.  117 (2020)  34 - p. 20785-20793 , 2020
Link: https://doi.org/10.1073/..
 
?
15

Epigenetic silencing of TGFBI confers resistance to trastuz..:

Palomeras, Sònia ; Diaz-Lagares, Ángel ; Viñas, Gemma...
Breast Cancer Research.  21 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
1-15